Non-immune role of immune cells in MS
Summary
This study aims to understand how certain immune cells (B cells) contribute to the development of MS. Traditionally it is thought that immune cells cause inflammation in the brain of MS patients through autoimmune mechanisms. We believe that B cells might additionally contribute to this disease in a completely novel way by promoting brain degeneration, much like what occurs in Alzheimer's and other neurodegenerative diseases.
Eligibility
Eligible gender: Male, Female, Transgender, Other
Eligible ages: 18 to 80
Accepts healthy participants: Yes
Inclusion criteria:
1) any patient diagnosed with MS at any stage of the disease
2) healthy controls
3) patients with other neurodegenerative diseases that are unrelated to MS, like Alzheimer's and Parkinson's disease
4) other autoimmune diseases like lupus
5) cancer of the lymphatic system (lymphoma)
Exclusion criteria:
Patients receiving B cell-depleting medications (such as rituximab or ocrelizumab) are not eligible
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
Dr. Peter K. Stys
Principal investigator:
Peter Stys
Clinical trial:
No
REB-ID:
REB17-2125